Verteporfin therapy for choroidal neovascularization: from concept to proof of efficacy.
Sickenberg
M
M
Hôpital Opthalmic Jules Gonin, Lausanne, Switzerland. michel.sickenberg@bluewin.ch
D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy*; D005451:Fluorescein Angiography; D006801:Humans; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D016896:Treatment Outcome; D000077362:Verteporfin
D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin